— Know what they know.
Not Investment Advice

TAUG OTC

Tauriga Sciences, Inc.
1W: -90.0% 1M: -90.0% 3M: -90.0% 1Y: -100.0% 3Y: -100.0% 5Y: -100.0%
$0.00
Last traded 2023-08-11 — delisted
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · $2999 mcap · 293M float · 0.0005% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range1.0E-5-0.011
Volume5,000
Avg Volume1,562
Beta-0.73
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSeth M. Shaw
Employees2
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2002-12-11
4 Nancy Court
Wappingers Falls, NY 12590
US
917 796 9926
About Tauriga Sciences, Inc.

Tauriga Sciences, Inc. (TAUG) is primarily engaged in the manufacturing and distribution of its cannabidiol (CBD) infused chewing gum, sold under the brand name Tauri-Gum. The company also offers a diverse product portfolio, which includes a line of anti-nausea solutions. Its extensive collection of skincare items features CBD facemasks, daily moisturizers, anti-wrinkle creams (including specialized versions for dream, hand, and foot, often formulated with hemp seed oil), massage and body oils, body revive roll-ons, transdermal patches, and body sprays. Additionally, Tauriga Sciences provides a rainbow deluxe sampler pack, non-GMO CBD dietary supplements, and a variety of CBD-infused scented bath bombs. The firm distributes its merchandise through its e-commerce platform, various distributors, and wholesale channels. Notably, Tauriga Sciences has established a partnership with Aegea Biotechnologies, Inc. to collaborate on the development of a rapid, multiplex COVID-19 (novel coronavirus) diagnostic test. Established in 2001, the company maintains its corporate headquarters in Wappingers Falls, New York.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Rosati James V 0 — 2021-04-01
Sferruzzo Chris 0 — 2021-04-01
Lacey Kevin Patrick 0 — 2017-07-05
Lacey Kevin Patrick 0 — 2017-07-05
Graham Thomas James S-Sale 600,000 $0.00 2016-09-14

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms